• Proteinase K for DNA and EV Sample Workflows

  2026-08-08

  Proteinase K combines broad protein digestion with tolerance to SDS, EDTA, and varied incubation conditions, making it useful for genomic DNA isolation and controlled extracellular-vesicle assays. This guide translates its biochemical profile into practical workflows, assay controls, and troubleshooting strategies inspired by recent Candida albicans EV research.

• Foretinib: From Kinase Potency to Translational Insight

  2026-08-07

  Foretinib (GSK1363089) offers a strategic way to study how coordinated MET and VEGFR pathway inhibition affects proliferation, motility, invasion, and metastasis. This thought-leadership guide shows translational researchers how to move beyond single-endpoint viability assays toward response profiling that better separates growth arrest from cell death.

• Hydroxytyrosol: Optimized Workflows for Oxidative Stress Res

  2026-08-07

  Hydroxytyrosol, a potent 4-(2-hydroxyethyl)benzene-1,2-diol, delivers high reproducibility and robust antioxidant control in cardiovascular, inflammation, and kidney disease models. This guide distills actionable protocols, advanced troubleshooting, and translational insights, enabling researchers to maximize data quality and experimental impact.

• Merbromin as a Selective 3CLpro Inhibitor: Implications for

  2026-08-06

  This study identifies merbromin as a potent, mixed-type inhibitor with high selectivity for the SARS-CoV-2 main protease (3CLpro), distinguishing it from broad-spectrum serine proteases such as Proteinase K. The findings advance assay specificity and inhibitor profiling for antiviral drug discovery.

• Lamotrigine and Aromatase (CYP19) Inhibition in Epilepsy Res

  2026-08-06

  Jacobsen et al. systematically evaluated the ability of antiepileptic drugs, including Lamotrigine, to inhibit the human aromatase enzyme (CYP19) in vitro. Their study provides quantitative evidence that Lamotrigine can suppress CYP19 activity, raising important considerations for steroid hormone regulation and endocrine effects in epilepsy research.

• p-Cresyl Sulfate in Endothelial Dysfunction and Calcificatio

  2026-08-05

  p-Cresyl sulfate from APExBIO enables precise modeling of uremia-driven cardiovascular risk by directly targeting the klotho/SIRT1 axis in endothelial and valvular calcification workflows. This guide translates the latest mechanistic insights and protocol optimizations into actionable strategies for robust cardiovascular and renal disease research.

• HyperScribe T7 High Yield RNA Synthesis Kit in mRNA Research

  2026-08-05

  The HyperScribe™ T7 High Yield RNA Synthesis Kit streamlines high-yield in vitro transcription workflows for advanced mRNA applications, including targeted neurotherapeutic delivery and RNA vaccine development. Its consistent, scalable output and compatibility with diverse RNA modifications empower researchers to rapidly generate functional RNA for complex translational studies.

• Propranolol: Applied Workflows for Cardiovascular & Memory R

  2026-08-04

  Propranolol’s dual β1/β2 antagonism powers reproducible cardiovascular regulation, emotional memory modulation, and metabolic research. This article delivers data-backed workflows, protocol parameters, and troubleshooting strategies to maximize research outcomes using APExBIO’s high-purity Propranolol.

• Merbromin as a Mixed-Type SARS-CoV-2 3CLpro Inhibitor: Insig

  2026-08-04

  The referenced study identifies Merbromin (mercury dibromofluorescein disodium salt) as a selective, mixed-type inhibitor of the SARS-CoV-2 main protease (3CLpro), using high-throughput screening and kinetic analysis. These findings provide mechanistic insight and a scaffold for further antiviral inhibitor development, with practical implications for enzyme inhibition assay design and protein–ligand probe applications.

• Prunin Targets SVA IRES to Suppress Viral Replication in Viv

  2026-08-03

  This study identifies prunin as a potent inhibitor of Senecavirus A (SVA) replication, acting through disruption of the internal ribosome entry site (IRES) translation mechanism. The findings reveal new host-virus interactions and suggest a strategic direction for antiviral development targeting IRES-mediated translation.

• ML365: Transforming Neuroinflammation Research via TASK1 Inh

  2026-08-03

  This article examines the strategic significance of ML365—a potent and selective TASK1 potassium channel inhibitor—in translational research on neuroinflammation and cognitive impairment. Integrating mechanistic insights from recent studies with practical workflow recommendations, it guides researchers on leveraging ML365 for target validation, assay optimization, and advancing preclinical models of postoperative cognitive dysfunction (POCD). This discussion uniquely bridges molecular pharmacology with translational outcomes, providing a critical roadmap for next-generation ion channel research.

• Unveiling EZ Cap™ Firefly Luciferase mRNA: Advanced mRNA Rep

  2026-08-02

  Explore how EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure delivers superior translation efficiency and stability for cutting-edge molecular biology applications. This article uniquely bridges mRNA design, LNP delivery science, and practical assay optimization.

• A-1331852: Precision BCL-XL Inhibition for Apoptosis Assay I

  2026-08-01

  Discover how A-1331852, a potent BCL-XL inhibitor, advances apoptosis assay design and targeted cancer research. This article offers unique protocol insights, deeper mechanistic clarity, and strategic guidance beyond existing resources.

• BAY-826: Potent Small Molecule Inhibitor for Retinal Models

  2026-07-31

  BAY-826 empowers researchers to dissect neurovascular signaling pathways in retinal disease models with unmatched precision. Its nanomolar potency and workflow flexibility enable robust, reproducible inhibition of angiopoietin and pigment epithelium-derived factor (PEDF) axes. Designed for rigorous cellular and biochemical assays, BAY-826 is a critical tool for advancing neuroprotection and anti-angiogenic research.

• Multiplexed mRNA and Protein Detection in Avian Hair Cell Re

  2026-07-31

  This protocol paper details a robust workflow for inducing and analyzing sensory hair cell loss and regeneration in the avian inner ear. By combining targeted ototoxic injury, advanced multiplexed mRNA detection, immunohistochemistry, and S-phase labeling, the study advances the toolkit for dissecting regenerative mechanisms with high spatial and molecular resolution.

16154 records 1/1077 page Next 12345 下5页 Last page